Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 7, 2012; 18(21): 2661-2667
Published online Jun 7, 2012. doi: 10.3748/wjg.v18.i21.2661
Table 1 General characteristics of the study population n (%)
Totaln = 2242FHx (-)n = 2077 (92.6%)FHx (+)n = 165 (7.4%)P value
GenderMale1765 (78.7)1639 (78.9)126 (76.4)0.441
Female477 (21.3)438 (21.1)39 (23.6)
AgeMedian (min-max)57.0 (18.0-89.0)57.0 (18.0-89.0)52.0 (29.0-79.0)< 0.0001
< 201 (0.1)1 (0.1)0 (0.0)< 0.001
20-2913 (0.5)12 (0.6)1 (0.6)
30-39112 (5.0)99 (4.8)13 (7.9)
40-49458 (20.4)410 (19.7)48 (29.1)
50-59722 (32.2)661 (31.8)61 (37.0)
60-69640 (28.6)606 (29.2)34 (20.6)
70-79256 (11.4)248 (11.9)8 (4.8)
≥ 8040 (1.8)40 (1.9)0 (0.0)
EtiologyHBV1683 (75.1)1548 (74.5)135 (81.8)0.236
HCV296 (13.2)280 (13.5)16 (9.6)
Alcohol70 (3.1)68 (3.3)2 (1.2)
Combined32 (1.4)31 (1.5)1 (0.6)
Others50 (2.2)45 (2.2)5 (3.0)
Unknown111 (5.0)105 (5.0)6 (3.6)
HBVHBV (+)1713 (76.4)1577 (75.9)136 (82.4)0.058
HBV (-)529 (23.6)500 (24.1)29 (17.6)
HCVHCV (+)315 (14.1)298 (14.3)17 (10.3)0.15
HCV (-)1927 (85.9)1779 (86.7)148 (89.6)
StageI185 (8.3)167 (8.0)18 (10.9)0.221
II655 (29.2)602 (29.0)54 (32.7)
III648 (28.9)610 (29.4)38 (23.1)
IVa and IVb753 (33.6)698 (33.6)55 (33.3)
Lab,ALT (U/L)47.0 (3.0-3505.0)47.0 (3.0-3505.0)47.5 (3.0-840.0)0.987
median (min-max)TB (mg/mL)1.1 (0.1-47.6)1.1 (0.1-47.6)1 (0.1-26.0)0.868
Alb (g/dL)3.5 (1.2-9.6)3.5 (1.2-9.6)3.7 (1.6-5.0)0.106
Platelet (x 103/μL)121.5 (8.0-1084.0)121.0 (18.0-1084.0)133.0 (8.0-635.0)0.181
Tumor markers,AFP (ng/ mL)69.1 (0.0-529 470.0)67.00 (0.0-529 470.0)110.8 (1.1-53 606.0)0.972
median (min-max)PIVKA-II (Mau/mL)88.0 (1.0-16 636.8)92.0 (1.0-16 636.8)80.0 (6.0-2000.0)0.990